A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute…

Overview of attention for article published in Annals of Hematology, February 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Dimensions has found 41 publications that cite this research output.

Article in Transfusion (February 2024)

Article in Stem Cells (December 2023)

Article in Hematology (June 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.